FI
NBRV

Fosun International’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Fosun International’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,666
Closed -$1.48M – 320
2019
Q2 		$1.48M Hold
2,666
– – 0.1% 129
2019
Q1 		$1.59M Buy
+2,666
New +$1.45M 0.1% 119

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fosun International's NBRV Position: Q3 2019 in Review

Fosun International sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2019, closing a stake of 2,666 shares — an estimated $1.48M sold.

Fosun International first reported a position in NBRV in Q1 2019 and held it in 2 quarters. The position peaked at $1.59M in Q1 2019. 44 funds tracked by Wall St. Rank hold NBRV as of Q3 2019.

  • Fosun International reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 2,666 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2019, an estimated $1.48M.
  • Fosun International first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q1 2019 and held it in 2 quarters.
  • Fosun International's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.59M in Q1 2019.
  • 44 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.